Marketing-authorisation holder · Canada
Zoetis Canada Inc
177 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
177 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 177
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A180180 mg / ml · Solution | Danofloxacin | Canada | Marketed | 2005 |
| ALFAXAN MULTIDOSE10 mg / ml · Solution | Alfaxalone | Canada | Marketed | 2018 |
| AMIGLYDE-V250 mg / ml · Solution | Amikacin | Canada | Marketed | 1998 |
| AMOXIL100 mg · Tablet | Amoxicillin | Canada | Marketed | 1986 |
| ANTIROBE75 mg · Capsule | Clindamycin | Canada | Marketed | 1992 |
| ANTIROBE150 mg · Capsule | Clindamycin | Canada | Marketed | 1991 |
| ANTIROBE25 mg · Capsule | Clindamycin | Canada | Marketed | 1991 |
| ANTIROBE AQUADROPS25 mg / ml · Solution | Clindamycin | Canada | Not marketed | 1990 |
| APOQUEL16 mg · Tablet | Oclacitinib | Canada | Marketed | 2016 |
| APOQUEL3.6 mg · Tablet | Oclacitinib | Canada | Marketed | 2016 |
| APOQUEL3.6 mg · Tablet (Chewable) | Oclacitinib | Canada | Marketed | 2023 |
| APOQUEL5.4 mg · Tablet (Chewable) | Oclacitinib | Canada | Marketed | 2023 |
| APOQUEL16 mg · Tablet (Chewable) | Oclacitinib | Canada | Marketed | 2023 |
| APOQUEL5.4 mg · Tablet | Oclacitinib | Canada | Marketed | 2016 |
| BUPRIXA0.3 mg / ml · Solution | Buprenorphine | Canada | Authorised | |
| CERENIA16 mg · Tablet | Maropitant | Canada | Marketed | 2008 |
| CERENIA24 mg · Tablet | Maropitant | Canada | Marketed | 2008 |
| CERENIA160 mg · Tablet | Maropitant | Canada | Marketed | 2008 |
| CERENIA60 mg · Tablet | Maropitant | Canada | Marketed | 2008 |
| CERENIA10 mg / ml · Solution | Maropitant | Canada | Marketed | 2008 |
| CESTEX12.5 mg · Tablet | Epsiprantel | Canada | Marketed | 1992 |
| CESTEX25 mg · Tablet | Epsiprantel | Canada | Marketed | 1992 |
| CIDR 13801.38 g · Insert | Progesterone | Canada | Marketed | 2009 |
| CIDR 3300.35 g · Insert | Progesterone | Canada | Marketed | 2011 |
| CLAVAMOX200 mg + 50 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 177 | 130 | 47 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.